K

Kiniksa Pharmaceuticals Ltd
D

KNSA

38.930
USD
0.19
(0.49%)
مغلق
حجم التداول
26,899
الربح لكل سهم
1
العائد الربحي
-
P/E
779
حجم السوق
2,885,011,515
أصول ذات صلة الأخبار المقالات

العنوان: Kiniksa Pharmaceuticals International plc

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.